Oli Hudson
Why diagnostics is the next big challenge for NHS cancer services
The next decade will see a new wave of advanced biotech capable of assisting enormous strides forward in cancer care, with potential for safer, more effective treatment, improved survival and a better quality of life for patients. Read more
What did 2019 mean for oncology suppliers?
Oli Hudson, of Wilmington Healthcare, writes about the effect that reforms and initiatives surrounding cancer care during this calendar year have had on oncology suppliers. Read more
The X factor: the early impact of NHSX
Oli Hudson, of Wilmington Healthcare, explores the impact of NHSX, the NHS’s new joint organisation for digital, data and technology. Read more
New NHS framework takes aim at unwarranted variation
Oli Hudson, content director at Wilmington Healthcare, explores how the NHS aims to cut costs and improve efficiency to implement the Long Term Plan. Read more
credit: chrisdorney / Shutterstock.com
How the NHS is backing a new raft of medtech innovations
Oli Hudson, of Wilmington Healthcare, explores how the NHS is enabling more proven and cost-effective technology to be rolled out nationwide. Read more
Big changes ahead for NHS hospital services
Oli Hudson, of Wilmington Healthcare, explores the NHS’s bid to split urgent and planned care into separate sites and redesign specialist services. Read more
The potential effects of an NHS patient data sharing milestone
Oli Hudson, of Wilmington Healthcare, explores the implications of a new deal to create the country’s largest regional patient record. Read more
How can medtech help the NHS transform procurement?
NHS Supply Chain category tower service provider director, Mark Hart, explains what he needs from the medtech industry in a Wilmington Healthcare webinar. Read more
chrisdorney / Shutterstock.com
Medtech innovation is key for new NHS plan
Steve How and Oli Hudson, of Wilmington Healthcare, explore some of the new opportunities for medtech in the NHS Long-term Plan. Read more
How will category towers tackle NHS procurement challenges?
Steve How and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore how the procurement towers plan to reduce unwarranted variation in the NHS supply chain. Read more
Value for money: what does it mean in the new NHS procurement landscape?
Oli Hudson, of the Wilmington Healthcare Consulting Team, assesses the immediate and longer-term priorities of the NHS procurement category towers. Read more
How can medtech engage with key stakeholders in new NHS care models?
Oli Hudson, of the Wilmington Healthcare consulting team, explores the value of a blended learning approach, underpinned by data, insight and analysis. Read more
